Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Capital Employed (2021 - 2022)

Historic Return on Capital Employed for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Capital Employed fell 200.0% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.18% for FY2021, which is N/A changed from last year.
  • As of Q3 2022, Atea Pharmaceuticals' Return on Capital Employed stood at 0.05%, which was down 200.0% from 0.04% recorded in Q2 2022.
  • In the past 5 years, Atea Pharmaceuticals' Return on Capital Employed registered a high of 0.18% during Q4 2021, and its lowest value of 0.04% during Q2 2022.